As of 2025-06-30, the Relative Valuation of Revolution Medicines Inc (RVMD) is (65.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 36.91 USD, the upside of Revolution Medicines Inc based on Relative Valuation is -276.7%.
The range of the Relative Valuation is (53.09) - (72.74) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 22.6x | 18.8x |
| Forward P/E multiples | 16.5x - 26.9x | 21.7x |
| Fair Price | (53.09) - (72.74) | (65.24) |
| Upside | -243.8% - -297.1% | -276.7% |
| Date | P/E |
| 2025-06-27 | -11.46 |
| 2025-06-26 | -11.63 |
| 2025-06-25 | -11.92 |
| 2025-06-24 | -12.43 |
| 2025-06-23 | -12.43 |
| 2025-06-20 | -12.31 |
| 2025-06-18 | -12.39 |
| 2025-06-17 | -12.15 |
| 2025-06-16 | -12.34 |
| 2025-06-13 | -12.60 |
| 2025-06-12 | -12.76 |
| 2025-06-11 | -12.66 |
| 2025-06-10 | -13.03 |
| 2025-06-09 | -12.60 |
| 2025-06-06 | -12.75 |
| 2025-06-05 | -12.48 |
| 2025-06-04 | -12.53 |
| 2025-06-03 | -12.60 |
| 2025-06-02 | -12.62 |
| 2025-05-30 | -12.23 |
| 2025-05-29 | -12.13 |
| 2025-05-28 | -11.71 |
| 2025-05-27 | -11.48 |
| 2025-05-23 | -12.34 |
| 2025-05-22 | -12.04 |
| 2025-05-21 | -12.02 |
| 2025-05-20 | -12.56 |
| 2025-05-19 | -12.39 |
| 2025-05-16 | -12.27 |
| 2025-05-15 | -12.24 |
| 2025-05-14 | -12.25 |
| 2025-05-13 | -12.40 |
| 2025-05-12 | -13.00 |
| 2025-05-09 | -12.55 |
| 2025-05-08 | -13.01 |
| 2025-05-07 | -11.69 |
| 2025-05-06 | -11.62 |
| 2025-05-05 | -12.35 |
| 2025-05-02 | -12.64 |
| 2025-05-01 | -12.61 |
| 2025-04-30 | -12.53 |
| 2025-04-29 | -12.62 |
| 2025-04-28 | -12.87 |
| 2025-04-25 | -12.03 |
| 2025-04-24 | -11.98 |
| 2025-04-23 | -11.62 |
| 2025-04-22 | -11.44 |
| 2025-04-21 | -11.35 |
| 2025-04-17 | -11.41 |
| 2025-04-16 | -11.24 |